search
Back to results

Supraclavicular Versus Axillary Block for Arteriovenous (AV) Fistula Creation (CUGSCAB)

Primary Purpose

Arteriovenous Fistula, Brachial Plexus Block, Clinical Efficacy

Status
Not yet recruiting
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Supraclavicular block
Axillary block
Sponsored by
Sultan Qaboos University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Arteriovenous Fistula focused on measuring Arteriovenous fistula, brachial plexus block, ultrasound guided, complications, block recovery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age >18 years old Patients undergoing AV fistula creation in the antecubital fossa Exclusion Criteria: - Patient Refusal Hemodynamically unstable patient Local infection over the insertion site Coagulopathy Known allergy to Local Anaesthetic medications Abnormal anatomy Use of antiplatelet within 7 days of surgery

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Supraclavicular block

    Axillary block

    Arm Description

    In the supraclavicular group, the ultrasound probe will be positioned in the supraclavicular fossa, pointing caudad and locating the subclavian artery. The first rib is identified deep to the artery, and the hyperechoic pleura will be identified by sliding lung sign. The brachial plexus is consistently found with a characteristic ''honeycomb'' appearance lateral and superficial to the subclavian artery and superior to the first rib. The needle will be introduced through the skin from lateral to medial, in-plane with the transducer, with constant visualization, and directed toward the deep border of the nerve group. Three separate injections will be made at various sites in the bundle, tending to start deep, in the ''corner pocket'' close to the artery, and moving more superficially. The local anesthetics will be Lidocaine 2% 10 ml + Levobupivacaine 0.5% 10 ml.

    Patients in the axillary group are placed in the supine position with the arm to be blocked, abducted and externally rotated. After sterilization of the axilla, the Ultrasound probe will be placed parallel to the anterior axillary fold at the axilla to identify the axillary artery and surrounding radial, ulnar, and median nerve, appearing as hypo-echoic round structures around the axillary artery. The musculocutaneous nerve will also be identified between the coracobrachialis and biceps muscle or in either of them. Lidocaine 1% was infiltrated subcutaneously 1 cm lateral to the probe, and then 0.5% bupivacaine will be injected around branches of the brachial plexus. The local anesthetics will be Lidocaine 2% 10 ml + Levobupivacaine 0.5% 15 ml. In this block, 5-7 ml of local anesthetic will block each nerve.

    Outcomes

    Primary Outcome Measures

    Requirement of additional analgesics intraoperatively or block failure (conversion to general anaesthesia)
    Paracetamol 15 mg/kg or Fentanyl 0.5 mics/kg or local infiltration or change to General Anesthesia

    Secondary Outcome Measures

    Time of motor recovery of block
    The assessment will start from two hours after time 0 and will continue every 30 minutes till 6 hours and every hour till discharge or complete recovery of the block.
    Rate of complications
    Pneumothorax, Horner syndrome, Hematoma, Diaphragmatic paralysis, Local anaesthetic systematic toxicity (LAST)

    Full Information

    First Posted
    February 22, 2023
    Last Updated
    March 29, 2023
    Sponsor
    Sultan Qaboos University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05809258
    Brief Title
    Supraclavicular Versus Axillary Block for Arteriovenous (AV) Fistula Creation
    Acronym
    CUGSCAB
    Official Title
    Comparison of Efficacy of Ultrasound-Guided Supraclavicular and Axillary Block for Arterio-Venous Fistula Creation: An Observer-Blinded, Non-inferiority Randomized Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    May 2023 (Anticipated)
    Primary Completion Date
    December 2024 (Anticipated)
    Study Completion Date
    May 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Sultan Qaboos University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    This study compares the analgesic efficacy of supraclavicular brachial plexus nerve block to axillary nerve block techniques in adults undergoing AV fistula creation. Both these techniques will be done under ultrasound guidance, using the same local anesthetic drug. 120 patients will be included in this study, 60 patients for each technique. This study will help us know better regional anesthesia techniques, the additional need for analgesia/anesthesia, and the recovery rate following either of the blocks for AV fistula surgery. An interim analysis will be done after recruiting 50% of cases (30 cases) in both arms.
    Detailed Description
    Introduction An AV fistula creation is generally performed at the antecubital fossa under regional anesthesia. General anesthesia is associated with increased cardiorespiratory complications in patients with end-stage renal disease. Thus, in such patients, RA, such as a brachial plexus block (BPB), is favored for AVF creation. In this study comparison between two well-established and frequently used approaches of brachial plexus block: supraclavicular and axillary, will be compared. The supraclavicular block is one of several approaches used for the brachial plexus block. The block is performed at the level of the brachial plexus trunks, where almost the entire sensory, motor, and sympathetic innervation of the upper extremity is carried in just three nerve structures confined to a very small surface area. Indications for the supraclavicular block include elbow, forearm, and hand surgeries. The axillary block technique is relatively easy to approach and simple to perform and may be associated with a lower risk of complications than supraclavicular BPB. The supraclavicular has a slightly wider area of coverage and a supposedly higher rate of complications compared to the axillary approach when performed with a traditional approach without ultrasound guidance. Using ultrasound should reduce the rate of complications for both blocks. No randomized control study has compared the efficacy of both blocks for AV Fistula creation with ultrasound guidance. This study aims to determine a better anesthesia technique for AV fistula creation in terms of anesthesia efficacy, complications, and recovery. Method Study type: Randomized, Controlled, observer-blinded non-inferiority trial, with two parallel arms. Blinding: The observer, Anesthetist 2, and data analyst will be blinded. But the patient and the block performer both will know the block group. Randomization: The statistician will generate the block randomization sequence, and the file will be handed over to the principal investigator. The file will be accessed during randomization, and group allocation will be obtained and conveyed to the block performer (Anesthetist 1). The remaining will be kept securely with the principal investigator. The patient will be randomized into groups A (supraclavicular nerve block) and B (axillary nerve block). The randomization sequence will be kept locked with a password-protected file. Crossover: Nil Study duration: Prospective for 18-24 months, depending on the case recruitment rate. Number of groups: 2 Sample size: 120 cases, 60 in each group. Assessment: The patient will be assessed intraoperatively at 10 minutes after the block and every 5 minutes. The final assessment of block adequacy will be done 30 minutes after the block, and a decision will be taken on adequacy. The next assessment will be at two hours and 30 minutes after time 0 and will continue every hour till complete recovery of the block in PACU and ward. Target follow-up duration: The patient will be followed till complete recovery of muscle power of the upper limb. Eligibility Study Population: all adult>18 years old patients posted for AV fistula creation in the antecubital fossa. Inclusion Criteria: Age >18 years old Patients undergoing AV fistula creation in the antecubital fossa Exclusion Criteria: Patient Refusal Hemodynamically unstable patient Local infection over the insertion site Coagulopathy Known allergy to Local Anaesthetic medications. Grossly abnormal anatomy Severe chronic airways disease Primary Outcome: • Requirement of additional analgesics intraoperatively or block failure (conversion to general anesthesia) Secondary outcome: Time of motor recovery of block Rate of complications Comparison of change in brachial artery diameter at the elbow before and after block Study population: Sample size The estimated sample size is 120 (60 in each group). The estimation was based on the success rate reported in the literature (95%), the non-inferiority margin between supraclavicular and axillary brachial plexus block to be < 10%. The power was set at 80%, and the alpha error was set at 5%. The allocation ratio was 1:1. The software used for the sample size calculation is nMaster 2.0 sample size calculator. Method: Patients will be posted for surgery in the operating room list. An appropriate population, as per eligibility criteria, will be approached. An explanation of the study will be done in comprehensive language. The patient's rights will be explained to the patient/relatives. Informed consent will be taken on the consent form. As per the departmental schedule and protocol, a separate anesthetist will do the pre-anesthetic checkups. On the day of surgery, the patient will be premedicated per standard institutional guidelines; the intravenous cannula will be inserted in the ward. On arrival of the patients to the operative theatre, ASA monitors will be attached (ECG, non-invasive blood pressure, and SpO2). The patient will be positioned for the block, and the largest brachial artery diameter will be recorded with the help of the ultrasound. This will be done before attempting block, at the start and end of surgery. Following the study protocol, the block will be given as per randomization by one of the expert anesthesia consultants (Anesthetist 1). The supraclavicular and axillary block sites will be dressed for all patients to avoid disclosing the technique to Anesthetist 2 and the assessors. An independent observer will record all the timings and procedure details. At the end of the procedure, the patient will be shifted to PACU (Post-Anesthesia Care Unit). Assessment of the block: The block assessment will start after 10 minutes of finishing the block (Time 0) and will be repeated every 5 minutes until the start of surgery. If the anesthesia state is not achieved within 30 minutes of the block, rescue analgesia or general anesthesia will be given. Rescue analgesia will be given when the block is incomplete (only one segment/nerve dermatome will be spared). It will consist of Fentanyl 0.5 mics/kg aliquots followed by local infiltration with 1% Lidocaine by the surgeon and Paracetamol 15 mg/kg in the same sequence, one after another if previous rescue analgesia is not effective. General anesthesia will be given if there is a complete block failure (defined as no block in more than one nerve). Assessment of the block intraoperatively: The muscle power will be checked by asking the patient to flex and extend his forearm and adduct, abduct and oppose the thumb and all fingers. Motor blockade of the musculocutaneous nerve will be checked by elbow flexion, ulnar nerve by thumb adduction, radial by thumb abduction and median nerve by thumb opposition. The power will be graded on a three-point scale: 0=no block, 1=paresis, and 2=paralysis. Whereas sensory blockade will be assessed on another three-point scale with a cold test: 0=no block, 1=analgesia (can feel touch but not cold), and 2=anesthesia (cannot feel touch). Assessment of the block postoperatively: The assessment will start two hours 30 minutes after time 0 and will continue every hour till discharge or complete recovery of the block. Possible Complications: Pneumothorax Horner syndrome Vascular puncture and Hematoma Diaphragmatic paralysis Local anesthetic systematic toxicity (LAST) Prolonged block recovery Troubleshooting: Pneumothorax: Because of the proximity of the pleura to the brachial plexus at the clavicle's level, the lung's apex can be damaged. It is a rare complication; pneumothorax was a more frequent complication of the supraclavicular block before ultrasound use, with a reported incidence of 0.6% to 6.1%. Maintaining needle tip visibility at all times during needle advancement is critical while performing US-guided block., An urgent chest radiograph (CXR) will be requested if the pleura is punctured, and supplemental oxygen will be delivered. A general surgeon will insert a chest tube under local anaesthesia and connect to suction at a negative pressure of 20 cm H2O. A repeat CXR will be done to confirm the correct position of the chest tube and re-expansion of the lung. The chest tube will be removed a few days later upon the resolution of symptoms. Horner's syndrome may correspond to the diffusion of local anaesthetics in prevertebral spaces, ultimately involving the sympathetic nerves and communicating with cervical nerve trunks. It results from paralysis of the ipsilateral sympathetic cervical chain (stellate ganglion) caused by surgery, drugs (mainly high concentrations of local anaesthetics), local compression (hematoma or tumour), or inadequate perioperative positioning of the patient. It appears after the block with a specific triad (ptosis, miosis, and exophthalmos) and quickly disappears without any sequelae. Horner's syndrome may be described as an unpleasant side effect because it has no clinical consequences, and if it occurs, patients should be reassured and monitored closely. Vascular puncture and Hematoma: These are not commonly encountered with ultrasound guidance. Bleeding can be controlled by pressure, conservative treatment and surgical exploration if needed. Especially if a hematoma forms, it should be removed promptly. Comprehensive knowledge of anatomy and skills is crucial to avoid nerve injuries, so the blocks will be performed by experts and US-guided in this study. Diaphragmatic paralysis: the phrenic nerve lies in front of the anterior scalene muscle, and local anaesthetic injected around the proximal, i.e., interscalene, part of the plexus can, therefore, easily affect the phrenic nerve. Treatment is conservative and usually resolves within a few days to weeks. Ultrasonography was chosen to demonstrate diaphragmatic movement as it reliably shows the paradoxical movement of the diaphragm in the event of paralysis. LAST: It is rare as the blocks are usually US-guided, and drugs are given in smaller amounts than the toxic levels and given with frequent aspirations to prevent injecting into blood vessels. The following actions will be taken when managing local anaesthetic toxicity: Stop the local anaesthetic injection. Institute basic life support and call for assistance. Secure the airway, ventilate with 100% oxygen, and gain intravenous access. Seizures can be managed with a benzodiazepine or anaesthetic induction agent. If a cardiac arrest has occurred, commence advanced life support. Note that arrhythmias are often refractory, and resuscitation should be prolonged. Treatment with IntraLipid: An initial dose of 20% lipid emulsion at 1.5 ml/kg or a 100 ml bolus can be administered over a few minutes. This can be repeated after 5 minutes two or more times for persistent hemodynamic instability. The bolus(es) should immediately be followed by a continuous infusion at 0.25-0.5 ml/kg/min. The infusion should run for a minimum of 10 minutes after the return of hemodynamic stability. However, there are documented reports of recurrent systemic toxicity even after this. For this reason, patients should be admitted for at least 12 hours for observation and additional doses of intralipid as needed for rebound symptoms or hemodynamic compromise. Prolonged block recovery: This is not expected as the medication injected is fixed, and the drugs will be injected under ultrasound vision around nerves. If it occurs, 24 hours period will be given for observation. And if it still doesn't recover, then neurological advice will be sought. Data collection: This prospective study would entail the collection of the following patient-specific data: Demographic Data: Age, gender, ASA grading, comorbidities, surgery Lab Data: Routine blood investigations like complete blood count and coagulation profile. Anesthesia and block details: Type of airway device, hemodynamic, block details: block name, normal/abnormal anatomy, local anaesthetics injected; rescue analgesics needed, motor assessment and complications at 30 minutes after arrival and before discharge from PACU, postoperatively in Ward at every hour till muscle power recovery and after discharge at home on day 2 and 5. One assigned co-investigator will enter the recorded patient data with a code and no name into the password-protected master chart.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Arteriovenous Fistula, Brachial Plexus Block, Clinical Efficacy
    Keywords
    Arteriovenous fistula, brachial plexus block, ultrasound guided, complications, block recovery

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Parallel Assignment
    Model Description
    Two parallel arms of interventions, no crossover.
    Masking
    InvestigatorOutcomes Assessor
    Masking Description
    The investigator and assessor will be blinded. The block performer anaesthetist and the patient will know the technique.
    Allocation
    Randomized
    Enrollment
    120 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Supraclavicular block
    Arm Type
    Active Comparator
    Arm Description
    In the supraclavicular group, the ultrasound probe will be positioned in the supraclavicular fossa, pointing caudad and locating the subclavian artery. The first rib is identified deep to the artery, and the hyperechoic pleura will be identified by sliding lung sign. The brachial plexus is consistently found with a characteristic ''honeycomb'' appearance lateral and superficial to the subclavian artery and superior to the first rib. The needle will be introduced through the skin from lateral to medial, in-plane with the transducer, with constant visualization, and directed toward the deep border of the nerve group. Three separate injections will be made at various sites in the bundle, tending to start deep, in the ''corner pocket'' close to the artery, and moving more superficially. The local anesthetics will be Lidocaine 2% 10 ml + Levobupivacaine 0.5% 10 ml.
    Arm Title
    Axillary block
    Arm Type
    Active Comparator
    Arm Description
    Patients in the axillary group are placed in the supine position with the arm to be blocked, abducted and externally rotated. After sterilization of the axilla, the Ultrasound probe will be placed parallel to the anterior axillary fold at the axilla to identify the axillary artery and surrounding radial, ulnar, and median nerve, appearing as hypo-echoic round structures around the axillary artery. The musculocutaneous nerve will also be identified between the coracobrachialis and biceps muscle or in either of them. Lidocaine 1% was infiltrated subcutaneously 1 cm lateral to the probe, and then 0.5% bupivacaine will be injected around branches of the brachial plexus. The local anesthetics will be Lidocaine 2% 10 ml + Levobupivacaine 0.5% 15 ml. In this block, 5-7 ml of local anesthetic will block each nerve.
    Intervention Type
    Procedure
    Intervention Name(s)
    Supraclavicular block
    Other Intervention Name(s)
    brachial plexus block
    Intervention Description
    brachial plexus nerve block by supraclavicular route
    Intervention Type
    Procedure
    Intervention Name(s)
    Axillary block
    Other Intervention Name(s)
    brachial plexus block
    Intervention Description
    brachial plexus nerve block by axillary route
    Primary Outcome Measure Information:
    Title
    Requirement of additional analgesics intraoperatively or block failure (conversion to general anaesthesia)
    Description
    Paracetamol 15 mg/kg or Fentanyl 0.5 mics/kg or local infiltration or change to General Anesthesia
    Time Frame
    20 minutes to 2 hours 30 minutes
    Secondary Outcome Measure Information:
    Title
    Time of motor recovery of block
    Description
    The assessment will start from two hours after time 0 and will continue every 30 minutes till 6 hours and every hour till discharge or complete recovery of the block.
    Time Frame
    up to 24 hours
    Title
    Rate of complications
    Description
    Pneumothorax, Horner syndrome, Hematoma, Diaphragmatic paralysis, Local anaesthetic systematic toxicity (LAST)
    Time Frame
    up to 24 hours
    Other Pre-specified Outcome Measures:
    Title
    Brachial artery diameter
    Description
    Brachial artery diameter will be checked before and after the block
    Time Frame
    0 to 3 hours

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Age >18 years old Patients undergoing AV fistula creation in the antecubital fossa Exclusion Criteria: - Patient Refusal Hemodynamically unstable patient Local infection over the insertion site Coagulopathy Known allergy to Local Anaesthetic medications Abnormal anatomy Use of antiplatelet within 7 days of surgery
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jyoti Burad, MD, EDIC
    Phone
    +96899578636
    Email
    jyotiburad@yahoo.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Yousef Emam Abouelatta, MD
    Phone
    +96895725458
    Email
    aliyousefahmed@yahoo.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jyoti Burad, MD, EDIC
    Organizational Affiliation
    Sultan Qaboos University Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Links:
    URL
    https://doi.org/10.2147/lra.s250989
    Description
    Shrestha, N. et al. (2020) "delayed neurological recovery after ultrasound-guided brachial plexus block: A case report," Local and Regional Anesthesia, Volume 13, pp. 33-35. Available at: https://doi.org/10.2147/lra.s250989
    URL
    https://doi.org/10.4103/ija.ija_293_18
    Description
    Subbiah, V. et al. (2018) "Observational study of the efficacy of supraclavicular brachial plexus block for arteriovenous fistula creation," Indian Journal of Anaesthesia, 62(8), p. 616. Available at: https://doi.org/10.4103/ija.ija_293_18.
    URL
    https://doi.org/10.1155/2012/125346
    Description
    Walid, T. et al. (2012) "A case of Horner's syndrome following ultrasound-guided infraclavicular brachial plexus block," Case Reports in Anesthesiology, 2012, pp. 1-3. Available at: https://doi.org/10.1155/2012/125346.
    URL
    https://pubmed.ncbi.nlm.nih.gov/21928240/
    Description
    Monte, A.I. et al. (2011) "Comparison between local and regional anesthesia in arteriovenous fistula creation," The Journal of Vascular Access, 12(4), pp. 331-335. Available at: https://doi.org/10.5301/jva.2011.8560.
    URL
    https://openanesthesiajournal.com/VOLUME/12/PAGE/34/FULLTEXT/
    Description
    Hussien, R.M. and Ibrahim, D.A. (2018) "Ultrasound guided axillary brachial plexus block versus supraclavicular block in emergency crushed hand patients : A comparative study," The Open Anesthesia Journal, 12(1), pp. 34-41.
    URL
    https://www.bjan-sba.org/article/doi/10.1016/j.bjane.2019.10.005
    Description
    Ferré, F. et al. (2019) "Hemidiaphragmatic paralysis after ultrasound-guided supraclavicular block: A prospective cohort study," Brazilian Journal of Anesthesiology (English Edition), 69(6), pp. 580-586.
    URL
    https://pubmed.ncbi.nlm.nih.gov/24641639/
    Description
    Gauss, A. et al. (2014) "Incidence of clinically symptomatic pneumothorax in ultrasound-guided infraclavicular and supraclavicular brachial plexus block," Anaesthesia, 69(4), pp. 327-336.
    URL
    https://pubmed.ncbi.nlm.nih.gov/24686046/
    Description
    Arab, S.A. et al. (2014) "Ultrasound-guided supraclavicular brachial plexus block," Anesthesia & Analgesia, 118(5), pp. 1120-1125. Available at: https://doi.org/10.1213/ane.0000000000000155.
    URL
    https://doi.org/10.1213/ane.0b013e3181e42908
    Description
    Bhatia, A. et al. (2010) "Pneumothorax as a complication of the ultrasound-guided supraclavicular approach for brachial plexus block," Anesthesia & Analgesia, 111(3), pp. 817-819. Available at: https://doi.org/10.1213/ane.0b013e3181e42908
    URL
    https://bmcanesthesiol.biomedcentral.com/articles/10.1186/s12871-020-01136-1
    Description
    Gao, C. et al. (2020) "Comparison of regional and local anesthesia for arteriovenous fistula creation in end-stage renal disease: A systematic review and meta-analysis." Available at: https://doi.org/10.21203/rs.3.rs-25806/v1.
    URL
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292858/
    Description
    Nofal, W.H. et al. (2017) "Ultrasound-guided axillary brachial plexus block versus local infiltration anesthesia for arteriovenous fistula creation at the forearm for hemodialysis in patients with chronic renal failure," Saudi Journal of Anaesthesia
    URL
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839540/
    Description
    Stav, A. et al. (2016) "Comparison of the supraclavicular, infraclavicular and axillary approaches for ultrasound-guided brachial plexus block for surgical anesthesia," Rambam Maimonides Medical Journal, 7(2)

    Learn more about this trial

    Supraclavicular Versus Axillary Block for Arteriovenous (AV) Fistula Creation

    We'll reach out to this number within 24 hrs